Medical Toxicology and Applied Pharmacology

Welcome Message

Dear Speakers, Delegates, Exhibitors & Sponsors,

On behalf of the Organizing Committee, we are delighted to welcome you to the “4^th International Conference and Expo on Medical Toxicology and Applied Pharmacology”, scheduled to be held in Paris, France, on December 17–18, 2025.

This two-day international event serves as a premier forum for toxicologists, pharmacologists, clinical researchers, healthcare professionals, and regulatory experts from around the world to share cutting-edge discoveries, novel therapeutic insights, and real-world applications in the fields of toxicology, pharmacology, and drug safety.

Our 2025 edition is designed to foster collaboration, stimulate critical thinking, and advance the science and practice of medical toxicology and applied pharmacology. From keynote addresses by internationally acclaimed experts to interactive panel discussions, technical sessions, and hands-on workshops, this event offers invaluable opportunities for learning, networking, and showcasing innovation.

We look forward to welcoming you to Paris this December and to making the 4^th International Conference and Expo on Medical Toxicology and Applied Pharmacology an enriching, collaborative, and impactful experience.

For any queries, please contact Mr. Martin Brown, Program Coordinator.

Warm regards,
Organizing Committee
Toxicologycongress-2025

About the Conference

The 4^th International Conference and Expo on Medical Toxicology and Applied Pharmacology is a prestigious global gathering focused on advancing research and application in medical toxicology, drug development, and clinical pharmacology. The event will bring together experts from academia, clinical practice, government agencies, and industry to address the most pressing challenges and future trends in these dynamic disciplines.

    Theme: "Emerging Horizons in Toxicological Sciences and Pharmacological Innovation"

Through a carefully curated scientific agenda, the conference will feature plenary talks, oral and poster sessions, workshops, symposia, and exhibitions, all designed to bridge the gap between laboratory findings and clinical practice.

Who Should Attend?

This conference is ideal for professionals across diverse sectors who are engaged in pharmacology, toxicology, and related biomedical sciences, including:

• Medical Toxicologists
• Clinical Pharmacologists
• Drug Safety Experts
• Regulatory Affairs Specialists
• Pharmaceutical Scientists
• Forensic Toxicologists
• Environmental Health Scientists
• Physicians and Clinicians
• Academic Researchers and Educators
• Healthcare Policy Makers
• Graduate and Postgraduate Students
• CRO and Biotech Industry Representatives

Sessions and Tracks

1. Clinical and Medical Toxicology

This track focuses on the diagnosis, treatment, and management of poisoning and toxic exposures in clinical settings. It covers acute and chronic toxicological emergencies, overdose management, and the use of antidotes. Participants will explore clinical case studies, protocols for patient care, and advancements in toxicology diagnostics.

2. Applied Pharmacology and Drug Mechanisms

This session delves into the pharmacodynamics and pharmacokinetics of drugs, examining how medications interact with the body at molecular and cellular levels. Topics include drug absorption, distribution, metabolism, and elimination, as well as mechanisms behind therapeutic effects and adverse reactions. Attendees will gain insights into optimizing drug efficacy and safety.

3. Toxicogenomics and Molecular Toxicology

Exploring the interface between genomics and toxicology, this track highlights how genetic variations influence toxic responses. It covers molecular pathways of toxicity, gene-environment interactions, and novel techniques such as gene expression profiling. The session emphasizes personalized toxicology and emerging molecular biomarkers.

4. Regulatory Toxicology and Risk Assessment

This session addresses the frameworks and guidelines governing the safety evaluation of chemicals and pharmaceuticals. Topics include toxicological risk assessment, regulatory compliance, policy development, and global harmonization efforts. Attendees will learn about methodologies to ensure public health protection through rigorous safety standards.

5. Pharmacovigilance and Drug Safety Monitoring

Focusing on post-marketing drug safety, this track covers systems for detecting, assessing, and preventing adverse drug reactions. Discussions include global pharmacovigilance programs, risk communication, and strategies to enhance patient safety. Participants will explore the role of healthcare professionals and regulators in monitoring drug safety.

6. Occupational and Environmental Toxicology

This session highlights toxicological risks related to workplace exposures and environmental pollutants. It covers assessment of chemical hazards, health effects of long-term exposure, and preventive strategies. Emphasis is placed on protecting worker health and reducing environmental toxicant impact through policy and intervention.

7. Neurotoxicology and Behavioral Pharmacology

Exploring the effects of toxic substances on the nervous system, this track investigates neurobehavioral changes and neurodevelopmental disorders caused by exposure to toxins and drugs. It covers mechanisms of neurotoxicity, testing models, and therapeutic approaches for neurotoxic injuries. Behavioral outcomes and cognitive impairments are key discussion points.

8. Pediatric and Developmental Toxicology

This track focuses on the vulnerability of fetuses, infants, and children to toxic exposures. It examines developmental toxicants, congenital defects, and age-specific pharmacokinetics. Attendees will learn about risk assessment for sensitive populations and strategies to minimize harmful exposures during critical growth periods.

9. Natural Products and Toxic Herbs

Exploring the dual nature of herbal medicines as therapeutic agents and potential toxins, this session covers the safety evaluation of natural products. Topics include phytochemical analysis, herb-drug interactions, and toxicity screening. The track emphasizes evidence-based use of herbal remedies in clinical practice.

10. Translational Pharmacology

This track bridges basic research findings with clinical applications, focusing on how experimental pharmacology translates into new therapies. It covers drug development pipelines, biomarker discovery, and clinical trial design. The session encourages collaboration between laboratory scientists and clinicians to accelerate drug innovation.

11. Forensic and Analytical Toxicology

Focusing on the detection of toxins in medico-legal investigations, this session highlights analytical methods such as chromatography and mass spectrometry. It covers toxicological casework, interpretation of results, and legal implications. Participants will explore forensic applications and emerging technologies in toxicology analysis.

12. Nanotoxicology and Nanomedicine

This session examines the biological impact of engineered nanomaterials, addressing safety concerns related to their use in medicine and industry. Topics include nanoparticle interactions with cells, toxicological testing, and the development of nanomedicine for targeted drug delivery. The track discusses regulatory challenges and future prospects.

13. Cardiovascular and Hepatotoxic Effects

This track investigates drug- and chemical-induced toxicities affecting the heart and liver. It covers mechanisms of organ damage, clinical manifestations, and biomarkers for early detection. Attendees will learn strategies to prevent, diagnose, and manage cardiovascular and hepatic toxicities in patients.

14. Drug Discovery and Pharmacokinetics

Focusing on the early stages of drug development, this session explores screening methods, lead optimization, and pharmacokinetic profiling. It highlights advances in modeling absorption, distribution, metabolism, and excretion (ADME). The track provides insights into improving drug candidates’ safety and efficacy profiles.

15. Biomarkers in Toxicology

This session emphasizes the identification and application of biomarkers for detecting exposure and toxic effects. It covers molecular, biochemical, and imaging markers used in risk assessment and clinical monitoring. Participants will learn about the development of sensitive and specific tools to enhance personalized toxicology.

16. Veterinary Toxicology and Comparative Pharmacology

Exploring toxicological issues in animals, this track covers species-specific responses, toxicants in veterinary medicine, and comparative studies relevant to human health. It includes discussions on poisonings, antidotes, and regulatory considerations in veterinary pharmacology.

17. Chemical Warfare Agents and Antidotes

This session focuses on toxic agents used in chemical warfare and terrorism, discussing their mechanisms of action and clinical management. It covers detection methods, emergency response protocols, and development of effective antidotes. The track highlights preparedness and public health implications.

18. Immunotoxicology and Inflammatory Responses

Examining how toxicants affect the immune system, this track explores immune suppression, hypersensitivity, and inflammation caused by chemical exposures. It addresses mechanisms of immune modulation and the role of immunotoxicology in disease prevention and drug safety.

19. Precision Medicine and Pharmacogenomics

This session explores how genetic differences influence drug responses and toxicological risks. It covers pharmacogenomic testing, personalized therapy approaches, and integrating genetic data into clinical decision-making to optimize treatment and minimize adverse effects.

20. Artificial Intelligence and Digital Health in Pharmacology

This track discusses the integration of AI, machine learning, and digital technologies in drug discovery, safety monitoring, and patient care. Topics include predictive toxicology, digital biomarkers, telemedicine, and the future of AI-driven pharmacological research and healthcare delivery.

Participation & Presentation Options

Oral Presentation
30-minute sessions to present original research, clinical experiences, or conceptual developments. Includes 20–25 minutes of talk and 5–10 minutes of Q&A.

Workshops
Interactive 45–60 minute sessions focused on practical demonstrations, skill-building, or collaborative research techniques.

Poster Presentation
Designed for graduate and early-career researchers to present findings through visual abstracts. A 5–7 minute oral explanation is followed by interactive Q&A.

Webinar Presentation
Remote participants may submit a pre-recorded presentation, which will be aired during the conference for global virtual attendees.

E-Poster
E-posters will be showcased on the official website, with DOI-assigned abstracts published in the conference proceedings.

Symposium / Special Sessions
Expert-led thematic sessions, 60 minutes each, focusing on collaborative or interdisciplinary research areas.

Young Researchers Forum (YRF)
Short oral presentations (10–12 minutes) specifically for Ph.D. students and postdoctoral fellows.

Exhibition & Sponsorship Opportunities

Engage with a global audience of healthcare professionals, researchers, and decision-makers by becoming an Exhibitor or Sponsor. Showcase your services, products, and innovations to a targeted audience in toxicology and pharmacology.

For booth reservations and sponsorship details, contact:
contact@europeanmeets.com
WhatsApp: +44 2045861247

Visa Application

The Organizing Committee of the 4th International Conference and Expo on Medical Toxicology and Applied Pharmacology kindly informs all participants that we do not provide direct assistance with visa application procedures. Applicants may be required to submit several supporting documents, such as a Letter of Invitation, Letter of Abstract Acceptance, and Registration Payment Receipt to the respective embassy or consulate as part of their visa process.

Letter of Invitation:
Upon acceptance of your abstract and completion of registration, a formal Letter of Invitation will be issued in English. This letter serves to confirm your participation in the conference and may support your visa application.

Token Payment:
A token payment of USD 200 can be made to obtain an official payment receipt, which may be used as additional documentation when applying for your visa.

IMPORTANT NOTICE:
In the event your visa application is denied, please be advised that the Organizing Committee cannot intervene or influence the decision made by the Ministry of Foreign Affairs or the embassy. We will not correspond or communicate with any visa authorities on behalf of applicants. Registration fees will only be refunded upon official visa denial, provided that valid proof of rejection from the embassy or consulate is submitted to the conference secretaria

Abstract Submission Criteria & Eligibility

The Organizing Committee of the 4th International Conference and Expo on Medical Toxicology and Applied Pharmacology invites researchers, clinicians, academicians, and industry experts to submit abstracts for presentation. We welcome original research, reviews, case studies, and innovative methodologies covering all areas of medical toxicology, pharmacology, drug safety, risk assessment, and related fields.

Presentation Requirements:
All presenting authors must complete registration and are responsible for their own travel and accommodation expenses. Accepted presenters will receive an official Letter of Acceptance via email, which can be used for registration and visa applications. Accepted abstracts will be published in the official Conference Abstract Book and disseminated to all participants.

If the presenting author cannot attend in person, it is their responsibility to delegate a qualified co-author or colleague to present on their behalf. The Organizing Committee should be notified in advance to update the conference program accordingly.

Submission Formats:

• Oral Presentations: 20-30 minute slots including Q&A, organized by thematic sessions.
• Poster Presentations: Visual displays highlighting research findings, with dedicated viewing sessions.
• Workshops & Tutorials: Interactive sessions focusing on practical skills and emerging techniques, lasting 60 minutes.
• Symposium Sessions: Panel discussions or focused topic sessions lasting 60 minutes with audience engagement.

Market Analysis

The global market for medical toxicology and applied pharmacology is evolving rapidly, driven by increasing awareness of drug safety, environmental toxins, and advances in molecular toxicology. The rising prevalence of chronic diseases, adverse drug reactions, and environmental pollution highlights the need for innovative toxicological assessments and safer pharmacological interventions.

Key market segments include clinical toxicology, pharmacovigilance, nanomedicine, and regulatory toxicology, with pharmaceutical companies, healthcare providers, and research institutions playing pivotal roles. The integration of artificial intelligence and precision medicine is enhancing drug development and safety monitoring, creating new opportunities for growth.

Challenges include stringent regulatory requirements and the need for high-throughput screening methods. However, increasing investments in drug safety and biomarker research are expected to fuel market expansion, with projections indicating steady CAGR growth over the next decade. Europe, especially France, remains a significant hub for research and innovation in these fields.